Regenerative and translational medicine priority area
Two Calls for recruitment of LabEx Chairs in different thematic areas were launched.
New appointments 2014/2015
To develop integrative approaches towards understanding disease mechanisms and set up novel therapies, we complemented the existing expertise on neurodegenerative and neuromuscular disorders with recruitments in the growing field of neurodevelopmental disorders, with strong expertise and interest in genetics, animal models and phenotyping (in particular the mouse), translational approaches and innovative live imaging technologies.
- Prof. Jamel Chelly, from the Institut Cochin in Paris, joined IGBMC end of 2014 strengthening our links with the University Hospital.
Prof. Chelly dedicates his research to neurodevelopment disorders identifying genes for intellectual disability and malformations of cortical development. (More about the Team)
- Juliette Godin, junior group leader, will join in summer 2015, and reinforce the new neurodevelopmental research theme (More about the Team)
- Binnaz Yalcin, junior group leader, will join September 2015, focusing on the identification of novel genes responsible for neuroanatomical defects using the mouse as a model organism.
Teams expected to join in 2015/2016
The current local teams work towards approaches in regenerative medicine, analyze the regulatory mechanisms that program stem cell differentiation or develop differentiation protocols and in vitro models.
Recruitments are ongoing (view Call - closed) in the stem cell field along the scientific lines of development, cell biology, regeneration or ageing. The goal is to fill gaps within the current expertise pool and bridge out to the other LabEx INRT priorities.